Active ingredientBezafibrateCat. No. P-B072-001CAS 41859-67-0Family · Pharmaceutical analytical standards
Bezafibrate
A lipid-lowering drug of the fibrate family, introduced in the late 1970s: it mainly lowers blood triglycerides and raises HDL, the 'good' cholesterol. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Besides PPAR alpha, the usual target of fibrates, it also activates PPAR gamma and delta: this is why it is described as a PPAR 'pan-agonist', with effects on sugar metabolism too.
Go to the active ingredient →Active ingredientBezafibrateCat. No. P-B072-001CAS 41859-67-0
Pharmacopoeial impurityBezafibrate EP Impurity ACat. No. P-B072-002CAS 41859-57-8
Pharmacopoeial impurityBezafibrate EP Impurity CCat. No. P-B072-003CAS 2157488-46-3
Pharmacopoeial impurityBezafibrate EP Impurity DCat. No. P-B072-004CAS 41859-58-9
Pharmacopoeial impurityBezafibrate EP Impurity ECat. No. P-B072-005CAS 2732346-94-8
Isotopically labelledBezafibrate-d4Cat. No. P-B072-007CAS 1189452-53-6
ImpurityBezafibrate Impurity 1Cat. No. P-B072-009CAS 55458-78-1
ImpurityBezafibrate Impurity 2Cat. No. P-B072-010CAS 883800-52-0
Impurity3-Chloro-N-(4-hydroxyphenethyl)benzamideCat. No. P-B072-011CAS 84491-96-3
ImpurityBezafibrate Isopropyl EsterCat. No. P-B072-017CAS 153758-85-1
ImpurityN,O-Bis-(4-chlorobenzoyl)tyramineCat. No. P-B072-018CAS 41859-56-7No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceBezafibrate CRSEDQM code B1115000Family BezafibrateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.